Dominique Valeyre
Sorbonne
404 Papers
1.7K Citations
Dominique Valeyre is an academic researcher from Sorbonne. The author has contributed to research in topics: Medicine & Idiopathic pulmonary fibrosis. The author has an hindex of 69, co-authored 384 publications. Previous affiliations of Dominique Valeyre include St. Joseph Hospital & University of Paris.
Chat about Author
Papers
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
William D. Travis,Talmadge E. King,Eric D. Bateman,David A. Lynch,Frédrique Capron,Thomas V. Colby,Jean-François Cordier,Roland M. Dubois,Jeffrey R. Galvin,Philippe Grenier,David M. Hansell,Gary W. Hunninghake,Masanori Kitaichi,Nestor L. Müller,Jeffrey L. Myers,Sonoko Nagai,Andrew G. Nicholson,Ganesh Raghu,Benoit Wallaert,Christian Brambilla,Kevin K. Brown,Andrew L. Cherniaev,Ulrich Costabel,David B. Coultas,Gerald S. Davis,Maurits G. Demedts,William W. Douglas,Jim J. Egan,Anders Eklund,Leonarda M. Fabbri,Craig A. Henke,Richard Hubbard,Y. Inoue,Takateru Izumi,H. M. Jansen,Ian Johnston,Dong Soon Kim,Nasreen Khalil,Fiona R. Lake,Giuseppe Lungarella,Joseph P. Lynch,Douglas W. Mapel,Fernando J. Martinez,Richard A. Matthay,Lee S. Newman,Paul W. Noble,Ken Ohta,Dario Olivieri,Luis A. Ortiz,Venerino Poletti,Robert Rodriguez-Roisin,William N. Rom,Jay Hoon Ryu,Paulo Hilário Nascimento Saldiva,Raúl H Sansores,Marvin L. Schwarz,Moisés Selman,Cecelia M. Smith,Zhaohui Tong,Zarir F Udwadia,Dominique Valeyre,Athol U. Wells,Robert A. Wise,Antonio Xaubet,Emilio Alvarez Fernandez,Elisabeth Brambilla,Vera Luiza Capelozzi,Andrew Cherniaev,Peter Dalquen,Gerhard Dekan,Philip S. Hasleton,James C. Hogg,N. A. Jambhekar,Anna Luise A Katzenstein,Michael Koss,Osamu Matsubara,Klaus Michael Müller,F. B.J.M. Thunnissen,James A. Waldron,Wei Hua Li,Paul J. Friedman,Martin Remy-Jardin,Theresa C. McLoud +82 more
TL;DR: The Diagnostic Process Is Dynamic Clinical Evaluation Radiological Evaluation Role of Surgical Lung Biopsy Unclassifiable Interstitial Pneumonia Bronchoalveolar Lavage Fluid Evaluation Idiopathic Pulmonary Fibrosis.
4.1K
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis,Ulrich Costabel,David M Hansell,Talmadge E. King,David A. Lynch,Andrew G. Nicholson,Christopher J. Ryerson,Jay H. Ryu,Moisés Selman,Athol U. Wells,Jurgen Behr,Demosthenes Bouros,Kevin K. Brown,Thomas V. Colby,Harold R. Collard,Carlos Robalo Cordeiro,Vincent Cottin,Bruno Crestani,Marjolein Drent,Rosalind F. Dudden,Jim Egan,Kevin R. Flaherty,Cory M. Hogaboam,Yoshikazu Inoue,Takeshi Johkoh,Dong Soon Kim,M Kitaichi,James E. Loyd,Fernando J. Martinez,Jeffrey L. Myers,Shandra Protzko,Ganesh Raghu,Luca Richeldi,Nicola Sverzellati,Jeffrey J. Swigris,Dominique Valeyre +35 more
TL;DR: This update is a supplement to the previous 2002 IIP classification document and outlines advances in the past decade and potential areas for future investigation.
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara,Yumiko Yoshioka,Akihiko Kitoh,Tomoko Shima,Kajsa Wing,Akira Niwa,Christophe Parizot,Cécile Taflin,Toshio Heike,Dominique Valeyre,Alexis Mathian,Tatsutoshi Nakahata,Tomoyuki Yamaguchi,Takashi Nomura,Masahiro Ono,Zahir Amoura,Guy Gorochov,Guy Gorochov,Shimon Sakaguchi,Shimon Sakaguchi +19 more
TL;DR: The dissection of FoxP3(+) cells into subsets enables one to analyze Treg cell differentiation dynamics and interactions in normal and disease states, and to control immune responses through manipulating particular FoxP 3(+) subpopulations.
2.2K
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W. Noble,Carlo Albera,Williamson Z. Bradford,Ulrich Costabel,Marilyn K. Glassberg,David Kardatzke,Talmadge E. King,Lisa Lancaster,Steven A. Sahn,Javier Szwarcberg,Dominique Valeyre,Roland M. du Bois +11 more
TL;DR: In this article, the CAPACITY program was designed to confirm the results of a phase 2 study that suggested that pirfenidone, a novel antifibrotic and anti-inflammatory drug, reduces deterioration in lung function in patients with idiopathic pulmonary fibrosis.
2K
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
Jean Bousquet,Holger J. Schünemann,B. Samolinski,Pascal Demoly,Carlos E. Baena-Cagnani,Carlos E. Baena-Cagnani,Claus Bachert,Sergio Bonini,L.-P. Boulet,Philippe-Jean Bousquet,Jan Brozek,Giorgio Walter Canonica,Thomas B. Casale,Alvaro A. Cruz,W. J. Fokkens,João Fonseca,R. Gerth van Wijk,Lawrence Grouse,Tari Haahtela,N. Khaltaev,Piotr Kuna,Richard F. Lockey,K. C. Lødrup Carlsen,J Mullol,Robert M. Naclerio,Robyn E O'Hehir,K. Ohta,S. Palkonen,Nikolaos G. Papadopoulos,G. Passalacqua,Ruby Pawankar,David Price,Dermot Ryan,F. E. R. Simons,Alkis Togias,Dennis M. Williams,A. Yorgancioglu,Osman M. Yusuf,Werner Aberer,Mitsuru Adachi,Ioana Agache,Nadia Aït-Khaled,Cezmi A. Akdis,A. Andrianarisoa,I. Annesi-Maesano,I. Annesi-Maesano,I. J. Ansotegui,Ilaria Baiardini,Eric D. Bateman,A. Bedbrook,Bianca Beghe,M. Beji,E.H.D. Bel,A. Ben Kheder,K. S. Bennoor,K. C. Bergmann,F. Berrissoul,T. Bieber,C. Bindslev Jensen,Michael S. Blaiss,A. L. Boner,Jacques Bouchard,Fulvio Braido,Christopher E. Brightling,Andrew Bush,F. Caballero,Moises A. Calderon,M. A. Calvo,Paulo Augusto Moreira Camargos,Luis Caraballo,Kai-Håkon Carlsen,W. Carr,Alfonso Cepeda,Alfredo Cesario,Niels H. Chavannes,Y. Z. Chen,Anca-Mirela Chiriac,T. Chivato Pérez,E. Chkhartishvili,Giorgio Ciprandi,D. J. Costa,L. Cox,Adnan Custovic,Ronald Dahl,Ulf Darsow,F. De Blay,Diana Deleanu,Judah A. Denburg,P. Devillier,T. Didi,D. Dokic,William K. Dolen,H. Douagui,Ruta Dubakiene,Stephen R. Durham,Mark S. Dykewicz,Yehia El-Gamal,A. El-Meziane,R. Emuzyte,Alessandro Fiocchi,Monica Fletcher,Takeshi Fukuda,Amiran Gamkrelidze,J. E. Gereda,S. Gonzalez Diaz,M. Gotua,M. A. Guzman,P W Hellings,B. Hellquist-Dahl,Friedrich Horak,J. O. B. Hourihane,Peter H. Howarth,Marc Humbert,Juan Carlos Ivancevich,Catherine Jackson,J. Just,O. Kalayci,Michael A. Kaliner,Ali Fuat Kalyoncu,Thomas Keil,Paul K. Keith,G. Khayat,You Young Kim,B. Koffi N'Goran,Gerard H. Koppelman,Marek L. Kowalski,Inger Kull,Violeta Kvedariene,Désirée Larenas-Linnemann,L. T. Le,Catherine Lemière,Jing Li,Phillip Lieberman,Brian J. Lipworth,Bassam Mahboub,Mika J. Mäkelä,Finbarr C. Martin,Gailen D. Marshall,Fernando D. Martinez,Mohammad Reza Masjedi,Marcus Maurer,S. Mavale-Manuel,Angel Mazon,Erik Melén,Eli O. Meltzer,N. H. Mendez,Hans F. Merk,F. Mihaltan,Yousser Mohammad,M. Morais-Almeida,Antonella Muraro,S. Nafti,Leyla Namazova-Baranova,K. Nekam,Angelo Neou,Bodo Niggemann,Ewa Nizankowska-Mogilnicka,T. D. Nyembue,Y. Okamoto,Kimi Okubo,M. P. Orru,S. Ouedraogo,Cevdet Ozdemir,P. Panzner,Isabella Pali-Schöll,Hae-Sim Park,B. Pigearias,W. Pohl,Todor A. Popov,Dirkje S. Postma,Paul Potter,Klaus F. Rabe,J. Ratomaharo,Sakari Reitamo,J. Ring,Ronald C. Roberts,Barbara Rogala,Antonino Romano,M. Roman Rodriguez,J Rosado-Pinto,Lanny J. Rosenwasser,Menachem Rottem,Menachem Rottem,Mario Sánchez-Borges,G. K. Scadding,Peter Schmid-Grendelmeier,Aziz Sheikh,J. C. Sisul,Dirceu Solé,Talant Sooronbaev,V. Spicak,O. Spranger,Renato T. Stein,Stuart W. Stoloff,Jordi Sunyer,Andrzej Szczeklik,Ana Todo-Bom,Elina Toskala,Elina Toskala,Y. Tremblay,Rudolf Valenta,Antonio Valero,Dominique Valeyre,Arunas Valiulis,Erkka Valovirta,P. Van Cauwenberge,Olivier Vandenplas,C. van Weel,Pakit Vichyanond,Giovanni Viegi,Dai Wang,Magnus Wickman,Stefan Wöhrl,John Wright,Barbara P. Yawn,Panayiotis K. Yiallouros,H. J. Zar,M. E. Zernotti,Nanshan Zhong,Mihaela Zidarn,Torsten Zuberbier,C. S. Ang,Abay Baigenzhin,Daniel A. Boakye,Andrew Briggs,Peter Burney,William W. Busse,A.G. Chuchalin,H. Haddad,Sebastian L. Johnston,Manolis Kogevinas,Mark L Levy,Alireza Mohammadi,Sam Oddie,D. Rezagui,Ingrid Terreehorst,John O. Warner +236 more
TL;DR: Ten years after the publication of the ARIA World Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children.